| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.48▼ | 1.48▼ | 1.48▼ | 1.45▼ | 1.52▼ |
| MA10 | 1.50▼ | 1.50▼ | 1.50▼ | 1.49▼ | 1.61▼ |
| MA20 | 1.52▼ | 1.53▼ | 1.53▼ | 1.52▼ | 1.49▼ |
| MA50 | 1.57▼ | 1.61▼ | 1.62▼ | 1.62▼ | 2.51▼ |
| MA100 | 1.63▼ | 1.60▼ | 1.57▼ | 1.49▼ | 4.30▼ |
| MA200 | 1.53▼ | 1.50▼ | 1.58▼ | 2.09▼ | 3.39▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | -0.007▼ | -0.007▼ | -0.013▼ | 0.081▲ |
| RSI | 35.793▼ | 36.842▼ | 37.285▼ | 38.845▼ | 36.731▼ |
| STOCH | 26.505 | 15.530▼ | 15.530▼ | 24.023 | 35.201 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -79.167▼ | -71.212 |
| CCI | -211.130▼ | -182.153▼ | -182.153▼ | -170.439▼ | -73.085 |
|
Thursday, October 16, 2025 05:05 AM
FRAMINGHAM, Mass., Oct. 16, 2025 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/09/26 | 1.41 | 1.41 | 1.41 | 1.41 | 14,861 |
| 03/09/26 | 1.44 | 1.46 | 1.36 | 1.36 | 20,347 |
| 02/09/26 | 1.59 | 1.59 | 1.43 | 1.47 | 18,389 |
| 01/09/26 | 1.525 | 1.525 | 1.525 | 1.525 | 879 |
| 31/08/26 | 1.45 | 1.485 | 1.45 | 1.47 | 2,553 |
| 28/08/26 | 1.49 | 1.51 | 1.4584 | 1.51 | 3,301 |
| 27/08/26 | 1.50 | 1.60 | 1.4669 | 1.52 | 13,743 |
| 26/08/26 | 1.56 | 1.56 | 1.525 | 1.525 | 5,272 |
| 25/08/26 | 1.49 | 1.60 | 1.49 | 1.60 | 12,184 |
| 24/08/26 | 1.55 | 1.56 | 1.53 | 1.54 | 16,639 |
|
|
||||
|
|
||||
|
|